Synthesis, Single Crystal X-Ray Structure, and Antimicrobial Activity of 6-(1,3-Benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}pyrimidin-4(3<i>H</i>)-one

<table>Crystal packing showing intermolecular C–H<svg height="5.4250002" id="M64" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 19.450001 5.4250002" width="19.450001" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,5.363)"><path d="M215 255q0 -26 -16 -42t-40 -16q-25 0 -40.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5zM541 255q0 -26 -16 -42t-40 -16q-25 0 -40.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5zM867 255q0 -26 -16 -42t-40 -16q-25 0 -40.5 16t-15.5 42
q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5z" id="x22EF"></path></g>
</svg>O hydrogen bonds as dashed lines.</table>

Journal of Chemistry

fig2

Figure 2

Figure 2: Synthesis, Single Crystal X-Ray Structure, and Antimicrobial Activity of 6-(1,3-Benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}pyrimidin-4(3<i>H</i>)-one 

Figure 2 | Synthesis, Single Crystal X-Ray Structure, and Antimicrobial Activity of 6-(1,3-Benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}pyrimidin-4(3H)-one 